{"id":74941,"date":"2023-10-23T11:36:41","date_gmt":"2023-10-23T15:36:41","guid":{"rendered":"https:\/\/hitconsultant.net\/?p=74941"},"modified":"2023-10-23T11:37:03","modified_gmt":"2023-10-23T15:37:03","slug":"nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients","status":"publish","type":"post","link":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/","title":{"rendered":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"1262\" height=\"837\" src=\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769.jpeg\" alt=\"\" class=\"wp-image-74942\" srcset=\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769.jpeg 1262w, https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769-300x199.jpeg 300w, https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769-290x192.jpeg 290w, https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769-768x509.jpeg 768w\" sizes=\"(max-width: 1262px) 100vw, 1262px\" \/><\/figure>\n\n\n\n<p><strong>What You Should Know:<\/strong><\/p>\n\n\n\n<ul><li>Today,&nbsp;<a href=\"https:\/\/nucleusrad.com\/\">&nbsp;Nucleus RadioPharma<\/a>&nbsp;the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by&nbsp;<a href=\"https:\/\/www.eclipse.org\/\">Eclipse<\/a>&nbsp;and<a href=\"https:\/\/www.gehealthcare.com\/\">&nbsp;GE HealthCare<\/a>&nbsp;with participation from&nbsp;<a href=\"https:\/\/www.echo.com\/\">Echo Global<\/a>,&nbsp;<a href=\"https:\/\/www.foxchase.org\/locations\/fox-chase-cancer-center-main-campus?utm_source=google&amp;utm_medium=organic\">Fox Chase Cancer Center<\/a>,&nbsp;<a href=\"https:\/\/www.grangerllc.com\/\">Granger Management<\/a>,&nbsp;<a href=\"https:\/\/www.mayoclinic.org\/\">Mayo Clinic,<\/a>&nbsp;<a href=\"https:\/\/www.mercy.com\/\">Mercy Health<\/a>, and&nbsp;<a href=\"https:\/\/missouri.edu\/\">University of Missouri<\/a>.<\/li><li>With this round of funding, Nucleus RadioPharma will establish multiple new manufacturing facilities around the country, including Rochester, Minnesota, near Mayo Clinic, and build novel technology for the development, manufacturing, and distribution of radiopharmaceuticals.<\/li><\/ul>\n\n\n\n<p><strong>Making Radiopharmaceuticals Increasingly Accessible Nationwide<\/strong><\/p>\n\n\n\n<p>Radiopharmaceuticals offer a highly targeted approach to a wide variety of cancer types and stages. \u201cConceivably, many cancers have the potential to be treated with a properly designed radiopharmaceutical and yet, very few patients with cancer are receiving this kind of treatment,\u201d said Geoff Johnson, M.D., Ph.D., Chair of Nuclear Medicine, Mayo Clinic, and Chief Scientific Officer of Nucleus RadioPharma. Despite their promise, only a small fraction of patients are able to obtain these drugs due to limited production capacity and an outdated, fragmented supply chain. Nucleus RadioPharma was founded and built to ensure cancer patients can access potentially lifesaving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new therapies.<\/p>\n\n\n\n<p>In addition to its manufacturing capabilities, Nucleus RadioPharma will shape the development of a new supply chain network designed to move, track, and deliver materials to patients faster and more efficiently. This network will cover the entire process, from identifying target molecules and testing treatments to supporting regulatory approvals and delivering patient-ready medication. Nucleus will bring life-saving treatments to an even broader patient base with the completion of multiple large regional sites. To enable global logistics and distribution of these therapies, the company is developing novel software and hardware technologies.&nbsp;<\/p>\n\n\n\n<p>Nucleus RadioPharma is positioned to expedite the availability of targeted radiopharmaceutical therapies through several ongoing partnerships and collaborations. These will enable rapid initiation of clinical trials, full support for formulation, analytical method development, regulatory guidance, and commercial manufacturing.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>What You Should Know: Today,&nbsp;&nbsp;Nucleus RadioPharma&nbsp;the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by&nbsp;Eclipse&nbsp;and&nbsp;GE HealthCare&nbsp;with participation from&nbsp;Echo Global,&nbsp;Fox Chase Cancer Center,&nbsp;Granger Management,&nbsp;Mayo Clinic,&nbsp;Mercy Health, and&nbsp;University of Missouri. With this round of funding, Nucleus RadioPharma will establish multiple new manufacturing <a class=\"more-posts-link\" href=\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\">&#8230; Read More<\/a><\/p>\n","protected":false},"author":94,"featured_media":74942,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[25444],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.6 (Yoast SEO v20.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients -<\/title>\n<meta name=\"description\" content=\"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients\" \/>\n<meta property=\"og:description\" content=\"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-23T15:36:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-23T15:37:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1262\" \/>\n\t<meta property=\"og:image:height\" content=\"837\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Syed Hamza Sohail\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hitconsultant\" \/>\n<meta name=\"twitter:site\" content=\"@hitconsultant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Syed Hamza Sohail\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\"},\"author\":{\"name\":\"Syed Hamza Sohail\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/2c3b22c89b4967fe57f40b1f2fecab8f\"},\"headline\":\"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients\",\"datePublished\":\"2023-10-23T15:36:41+00:00\",\"dateModified\":\"2023-10-23T15:37:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\"},\"wordCount\":368,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hitconsultant.net\/#organization\"},\"articleSection\":[\"Life Sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\",\"url\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\",\"name\":\"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients -\",\"isPartOf\":{\"@id\":\"https:\/\/hitconsultant.net\/#website\"},\"datePublished\":\"2023-10-23T15:36:41+00:00\",\"dateModified\":\"2023-10-23T15:37:03+00:00\",\"description\":\"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026\",\"breadcrumb\":{\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hitconsultant.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life Sciences\",\"item\":\"https:\/\/hitconsultant.net\/category\/life-sciences\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hitconsultant.net\/#website\",\"url\":\"https:\/\/hitconsultant.net\/\",\"name\":\"\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/hitconsultant.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hitconsultant.net\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hitconsultant.net\/#organization\",\"name\":\"HIT Consultant Media\",\"url\":\"https:\/\/hitconsultant.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png\",\"contentUrl\":\"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png\",\"width\":\"1024\",\"height\":\"772\",\"caption\":\"HIT Consultant Media\"},\"image\":{\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409\",\"https:\/\/twitter.com\/hitconsultant\",\"http:\/\/www.linkedin.com\/company\/2489253\",\"https:\/\/www.pinterest.com\/hitconsultant\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/2c3b22c89b4967fe57f40b1f2fecab8f\",\"name\":\"Syed Hamza Sohail\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hitconsultant.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e3b32d24fb71fbe1a5b4e21c51b7ca22?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e3b32d24fb71fbe1a5b4e21c51b7ca22?s=96&d=mm&r=g\",\"caption\":\"Syed Hamza Sohail\"},\"url\":\"https:\/\/hitconsultant.net\/author\/ssohail\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients -","description":"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/","og_locale":"en_US","og_type":"article","og_title":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients","og_description":"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026","og_url":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/","article_publisher":"https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409","article_published_time":"2023-10-23T15:36:41+00:00","article_modified_time":"2023-10-23T15:37:03+00:00","og_image":[{"width":1262,"height":837,"url":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2023\/10\/IMG_2769.jpeg","type":"image\/jpeg"}],"author":"Syed Hamza Sohail","twitter_card":"summary_large_image","twitter_creator":"@hitconsultant","twitter_site":"@hitconsultant","twitter_misc":{"Written by":"Syed Hamza Sohail","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#article","isPartOf":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/"},"author":{"name":"Syed Hamza Sohail","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/2c3b22c89b4967fe57f40b1f2fecab8f"},"headline":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients","datePublished":"2023-10-23T15:36:41+00:00","dateModified":"2023-10-23T15:37:03+00:00","mainEntityOfPage":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/"},"wordCount":368,"commentCount":0,"publisher":{"@id":"https:\/\/hitconsultant.net\/#organization"},"articleSection":["Life Sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/","url":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/","name":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients -","isPartOf":{"@id":"https:\/\/hitconsultant.net\/#website"},"datePublished":"2023-10-23T15:36:41+00:00","dateModified":"2023-10-23T15:37:03+00:00","description":"Today,\u00a0\u00a0Nucleus RadioPharma\u00a0the world\u2019s first fully integrated development, manufacturing, and supply chain organization for radiopha\u2026","breadcrumb":{"@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hitconsultant.net\/2023\/10\/23\/nucleus-radiopharma-secures-56m-to-expand-radiopharmaceutical-treatments-for-cancer-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hitconsultant.net\/"},{"@type":"ListItem","position":2,"name":"Life Sciences","item":"https:\/\/hitconsultant.net\/category\/life-sciences\/"},{"@type":"ListItem","position":3,"name":"Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients"}]},{"@type":"WebSite","@id":"https:\/\/hitconsultant.net\/#website","url":"https:\/\/hitconsultant.net\/","name":"","description":"","publisher":{"@id":"https:\/\/hitconsultant.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hitconsultant.net\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hitconsultant.net\/#organization","name":"HIT Consultant Media","url":"https:\/\/hitconsultant.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/","url":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png","contentUrl":"https:\/\/hitconsultant.net\/wp-content\/uploads\/2012\/08\/hit_consultant_logo.png","width":"1024","height":"772","caption":"HIT Consultant Media"},"image":{"@id":"https:\/\/hitconsultant.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/HIT-Consultant-Media\/302199219847409","https:\/\/twitter.com\/hitconsultant","http:\/\/www.linkedin.com\/company\/2489253","https:\/\/www.pinterest.com\/hitconsultant\/"]},{"@type":"Person","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/2c3b22c89b4967fe57f40b1f2fecab8f","name":"Syed Hamza Sohail","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hitconsultant.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e3b32d24fb71fbe1a5b4e21c51b7ca22?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3b32d24fb71fbe1a5b4e21c51b7ca22?s=96&d=mm&r=g","caption":"Syed Hamza Sohail"},"url":"https:\/\/hitconsultant.net\/author\/ssohail\/"}]}},"_links":{"self":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts\/74941"}],"collection":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/users\/94"}],"replies":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/comments?post=74941"}],"version-history":[{"count":0,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/posts\/74941\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/media\/74942"}],"wp:attachment":[{"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/media?parent=74941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/categories?post=74941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hitconsultant.net\/wp-json\/wp\/v2\/tags?post=74941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}